NCT02529800View on ClinicalTrials.gov

Investigating the Pharmacokinetic Characteristics of HIP1402 in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Healthy
Interventions
DRUG

HIP1402

Tamsulosin HCl 0.4mg

DRUG

HGP0412

Tamsulosin HCl 0.2mg

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT02529800 - Investigating the Pharmacokinetic Characteristics of HIP1402 in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter